Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact

Pfizer has been tapped by Shanghai-based Zai Lab to help market the company’s antibacterial drug Xacduro in mainland China, the partners said Thursday. The companies did not disclose the financial terms of the deal, which is slated to run through November 2028.